Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD) Who Have Had an Inadequate Response to Antidepressants Alone

ClinicalTrials.gov ID: NCT03738215

Public ClinicalTrials.gov record NCT03738215. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 6:28 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Blind, Placebo-Controlled Study of Cariprazine as an Adjunct to Antidepressants in the Treatment of Patients With Major Depressive Disorder Who Have Had an Inadequate Response to Antidepressants Alone

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objective of this study is to evaluate the efficacy, safety and tolerability of cariprazine as an adjunctive treatment to antidepressant therapy (ADT) in patients with MDD who have had an inadequate response to antidepressants alone.

Study identification

NCT ID
NCT03738215
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AbbVie
Industry
Enrollment
759 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 8, 2018
Primary completion
Sep 29, 2021
Completion
Sep 29, 2021
Last update posted
Oct 24, 2022

2018 – 2021

United States locations

U.S. sites
65
U.S. states
25
U.S. cities
62
Facility City State ZIP Site status
Alea Research /ID# 234789 Phoenix Arizona 85012-2707
Atria Clinical Research /ID# 237988 Little Rock Arkansas 72209-7040
Woodland Research Northwest, LLC /ID# 236641 Rogers Arkansas 72758-6442
California Pharmaceutical Research Institute /ID# 236732 Anaheim California 92804-3738
Advanced Research Center /ID# 237957 Anaheim California 92805
Axiom Research /ID# 236268 Colton California 92324
ATP Clinical Research, Inc /ID# 236619 Costa Mesa California 92626-4607
ProScience Research Group /ID# 236442 Culver City California 90230-6632
Collaborative Neuroscience Research - Orange County /ID# 237639 Garden Grove California 92845
Irvine Clinical Research /ID# 237409 Irvine California 92614
Omega Clinical Trials LLC /ID# 238168 La Habra California 90631-3842
Synergy San Diego /ID# 236654 Lemon Grove California 91945-2956
Anderson Clinical Research /ID# 236627 Redlands California 92374-4555
Sharp Mesa Vista Hospital /ID# 235797 San Diego California 92123
Viking Clinical Research /ID# 236614 Temecula California 92591-6200
Olympian Clinical Research /ID# 237417 Clearwater Florida 33756
MD Clinical Hallandale Florida 33009
Reliable Clinical Research /ID# 234786 Hialeah Florida 33012-5830
CNS Healthcare - Jacksonville /ID# 238241 Jacksonville Florida 32256-6039
Space Coast Neuropsychiatric Research Institute /ID# 235765 Palm Bay Florida 32905
University of South Florida /ID# 234386 Tampa Florida 33606
Institute for Advanced Medical Research /ID# 236672 Alpharetta Georgia 30022-1142
iResearch Atlanta, LLC /ID# 237389 Decatur Georgia 30030
Psych Atlanta /ID# 235835 Marietta Georgia 30060
Capstone Clinical Research /ID# 236546 Libertyville Illinois 60048-5341
Pillar Clinical Research /ID# 235702 Lincolnwood Illinois 60712
NeuroPsychiatric Research Practice & Associate LTD /ID# 234636 Winfield Illinois 60190
Lake Charles Clinical Trials /ID# 237723 Lake Charles Louisiana 70629
J. Gary Booker MD APMC /ID# 234514 Shreveport Louisiana 71104
Pharmasite Research, Inc. /ID# 237395 Baltimore Maryland 21208
CBH Health LLC /ID# 234536 Gaithersburg Maryland 20877
Michigan Clinical Research Institute /ID# 234792 Ann Arbor Michigan 48105-3205
NeuroBehavioral Medicine Group /ID# 236671 Bloomfield Hills Michigan 48302
Precise Research Centers /ID# 236598 Flowood Mississippi 39232-8839
Millennium Psychiatric Associates LLC /ID# 235989 St Louis Missouri 63132
Alivation Research /ID# 236583 Lincoln Nebraska 68526-9474
Altea Research Institute /ID# 236726 Las Vegas Nevada 89102-1955
Hassman Research Institute /ID# 237501 Berlin New Jersey 08009
Integrative Clinical Trials /ID# 236656 Brooklyn New York 11229-3576
Manhattan Behavioral Medicine PLLC /ID# 236314 New York New York 10036
Finger Lakes Clinical Research /ID# 236578 Rochester New York 14618-1609
New Hope Clinical Research Inc. /ID# 234557 Charlotte North Carolina 28211
Richard Weisler MD, PA & Assoc /ID# 237424 Raleigh North Carolina 27609
Quest Therapeutics of Avon Lake /ID# 236282 Avon Lake Ohio 44012
CTI Clinical Trial and Consulting /ID# 236271 Cincinnati Ohio 45212
The Ohio State University Department of Psychiatry /ID# 234583 Columbus Ohio 43210
CincyScience /ID# 236391 West Chester Ohio 45069
IPS Research Company /ID# 237671 Oklahoma City Oklahoma 73106
Sooner Clinical Research /ID# 236346 Oklahoma City Oklahoma 73112
Oregon Center for Clinical Investigations, Inc. - Portland /ID# 236649 Portland Oregon 97214-2569
Lehigh Center for Clinical Research /ID# 236702 Allentown Pennsylvania 18104-5034
Coastal Carolina Research Center /ID# 235909 North Charleston South Carolina 29405
Psychiatric Consultants PC /ID# 235839 Franklin Tennessee 37067
Clinical Neuroscience Solutions - Memphis /ID# 237476 Memphis Tennessee 38119
Austin Clinical Trial Partners /ID# 236551 Austin Texas 78737
BioBehavioral Research of Austin /ID# 236477 Austin Texas 78759-5290
Houston Clinical Trials /ID# 234442 Bellaire Texas 77401-2928
FutureSearch Trials of Dallas, LP /ID# 236275 Dallas Texas 75231
Earle Research /ID# 236661 Friendswood Texas 77546
Red Oak Psychiatry Associates /ID# 236600 Houston Texas 77090-2641
AIM Trials /ID# 236369 Plano Texas 75093
Pillar Clinical Research LLC /ID# 234465 Richardson Texas 75080
Neuropsychiatric Associates LLC/DBA Woodstock Research Center /ID# 236087 Woodstock Vermont 05091
Northwest Clinical Research Center /ID# 237584 Bellevue Washington 98007
Core Clinical Research /ID# 236405 Everett Washington 98201

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 60 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03738215, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 24, 2022 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03738215 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →